A detailed history of Belmont Capital, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Belmont Capital, LLC holds 42,158 shares of PFE stock, worth $1.18 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
42,158
Previous 42,158 -0.0%
Holding current value
$1.18 Million
Previous $1.21 Million 3.63%
% of portfolio
0.32%
Previous 0.52%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

BUY
$26.13 - $33.94 $698,402 - $907,148
26,728 Added 173.22%
42,158 $1.21 Million
Q3 2023

Nov 13, 2023

BUY
$32.09 - $37.51 $32 - $37
1 Added 0.01%
15,430 $511,000
Q2 2023

Aug 10, 2023

BUY
$36.12 - $41.79 $5,165 - $5,975
143 Added 0.94%
15,429 $565,000
Q1 2023

May 09, 2023

SELL
$39.39 - $51.28 $23,988 - $31,229
-609 Reduced 3.83%
15,286 $623,000
Q3 2022

Oct 18, 2022

BUY
$43.76 - $53.42 $695,565 - $849,110
15,895 New
15,895 $696,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $157B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Belmont Capital, LLC Portfolio

Follow Belmont Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Belmont Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Belmont Capital, LLC with notifications on news.